High Bridge, NJ, United States of America

Sean A Evans

USPTO Granted Patents = 3 


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1987-1990

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Sean A Evans

Introduction

Sean A Evans is an accomplished inventor based in High Bridge, NJ (US), known for his significant contributions to the field of therapeutic compositions. With a total of three patents to his name, Evans has focused on developing innovative solutions that enhance the efficacy of interferon treatments.

Latest Patents

One of Evans' latest patents is for an interferon administration vehicle. This invention provides a topical preparation that includes a therapeutically effective amount of one or more interferons, a compatible vehicle base, protease inhibitors to reduce the decay of biological activity, and anti-microbial agents. The vehicle base is often prepared from a mixture of polyethylene glycols or may include hydroxyethyl cellulose as a thickening agent. Another notable patent is for a topical therapeutic composition containing an oxidation inhibitor system, which is designed to be substantially non-toxic and stable.

Career Highlights

Evans has made a mark in the pharmaceutical industry through his work at Interferon Sciences, Inc. His innovative approaches to drug formulation have the potential to improve patient outcomes significantly.

Collaborations

Throughout his career, Evans has collaborated with notable colleagues, including Douglas Testa and Leonard F Estis, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sean A Evans continues to be a pivotal figure in the development of therapeutic compositions, with his patents reflecting a commitment to advancing medical treatments. His work exemplifies the impact of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…